Equity Overview
Price & Market Data
Price: $4.48
Daily Change: +$0.19 / 4.24%
Daily Range: $4.15 - $4.48
Market Cap: $58,659,592
Daily Volume: 850
Performance Metrics
1 Week: 13.19%
1 Month: 40.66%
3 Months: 49.48%
6 Months: 58.30%
1 Year: 38.83%
YTD: 47.93%
Company Details
Employees: 45
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.